Skip to main content
. 2020 Sep 10;15(4):567–574. doi: 10.1093/ecco-jcc/jjaa184

Figure 2.

Figure 2.

Cumulative risk of clinical relapse in patients with ulcerative colitis [UC], treated to target of clinical remission, who achieve: [A] persistent symptomatic and endoscopic remission over two consecutive endoscopies; and [B] persistent symptomatic and endoscopic remission with concurrent histological remission over two consecutive endoscopies.